DENTALCORP HOLDINGS LTD (DNTL.CA) Stock Fundamental Analysis
TSX:DNTL - Toronto Stock Exchange - CA24874B1085 - Common Stock - Currency: CAD
Taking everything into account, DNTL scores 4 out of 10 in our fundamental rating. DNTL was compared to 16 industry peers in the Health Care Providers & Services industry. DNTL has a medium profitability rating, but doesn't score so well on its financial health evaluation. DNTL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
DNTL had positive earnings in the past year.
DNTL had a positive operating cash flow in the past year.
DNTL had negative earnings in each of the past 5 years.
DNTL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DNTL has a Return On Assets (-1.70%) which is in line with its industry peers.
DNTL's Return On Equity of -3.27% is fine compared to the rest of the industry. DNTL outperforms 62.50% of its industry peers.
With a Return On Invested Capital value of 1.20%, DNTL perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DNTL is significantly below the industry average of 8.14%.
The last Return On Invested Capital (1.20%) for DNTL is above the 3 year average (0.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.7% | ||
| ROE | -3.27% | ||
| ROIC | 1.2% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 3.38%, DNTL is doing good in the industry, outperforming 68.75% of the companies in the same industry.
In the last couple of years the Operating Margin of DNTL has grown nicely.
The Gross Margin of DNTL (49.51%) is better than 81.25% of its industry peers.
In the last couple of years the Gross Margin of DNTL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.38% | ||
| PM (TTM) | N/A | ||
| GM | 49.51% |
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DNTL is destroying value.
Compared to 1 year ago, DNTL has more shares outstanding
The number of shares outstanding for DNTL has been increased compared to 5 years ago.
The debt/assets ratio for DNTL has been reduced compared to a year ago.
2.2 Solvency
DNTL has an Altman-Z score of 0.82. This is a bad value and indicates that DNTL is not financially healthy and even has some risk of bankruptcy.
DNTL has a Altman-Z score of 0.82. This is comparable to the rest of the industry: DNTL outperforms 43.75% of its industry peers.
The Debt to FCF ratio of DNTL is 9.35, which is on the high side as it means it would take DNTL, 9.35 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.35, DNTL is doing good in the industry, outperforming 75.00% of the companies in the same industry.
A Debt/Equity ratio of 0.76 indicates that DNTL is somewhat dependend on debt financing.
DNTL has a better Debt to Equity ratio (0.76) than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.35 | ||
| Altman-Z | 0.82 |
ROIC/WACC0.17
WACC6.99%
2.3 Liquidity
DNTL has a Current Ratio of 0.98. This is a bad value and indicates that DNTL is not financially healthy enough and could expect problems in meeting its short term obligations.
DNTL's Current ratio of 0.98 is amongst the best of the industry. DNTL outperforms 81.25% of its industry peers.
A Quick Ratio of 0.82 indicates that DNTL may have some problems paying its short term obligations.
DNTL has a Quick ratio (0.82) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The earnings per share for DNTL have decreased by -4.88% in the last year.
Looking at the last year, DNTL shows a quite strong growth in Revenue. The Revenue has grown by 9.88% in the last year.
Measured over the past years, DNTL shows a quite strong growth in Revenue. The Revenue has been growing by 15.02% on average per year.
EPS 1Y (TTM)-4.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%9.94%
3.2 Future
DNTL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.52% yearly.
The Revenue is expected to grow by 10.58% on average over the next years. This is quite good.
EPS Next Y25.49%
EPS Next 2Y13.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.6%
Revenue Next 2Y10.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 22.31, which indicates a rather expensive current valuation of DNTL.
Compared to the rest of the industry, the Price/Earnings ratio of DNTL indicates a rather cheap valuation: DNTL is cheaper than 81.25% of the companies listed in the same industry.
DNTL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.43, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.47, DNTL is valued correctly.
DNTL's Price/Forward Earnings ratio is rather cheap when compared to the industry. DNTL is cheaper than 81.25% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DNTL to the average of the S&P500 Index (22.17), we can say DNTL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.31 | ||
| Fwd PE | 16.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DNTL is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DNTL indicates a rather cheap valuation: DNTL is cheaper than 81.25% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.15 | ||
| EV/EBITDA | 11.49 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DNTL's earnings are expected to grow with 13.52% in the coming years.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y13.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
DNTL has a Yearly Dividend Yield of 1.14%.
Compared to an average industry Dividend Yield of 3.21, DNTL pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.14, DNTL pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
5.2 History
DNTL is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y13.52%
EPS Next 3YN/A
TSX:DNTL (6/4/2025, 7:00:00 PM)
8.7
-0.14 (-1.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.43%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.65B
Analysts83.75
Price Target12.78 (46.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.14% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.79%
Min EPS beat(2)-32.39%
Max EPS beat(2)16.81%
EPS beat(4)2
Avg EPS beat(4)-20.75%
Min EPS beat(4)-69.72%
Max EPS beat(4)16.81%
EPS beat(8)5
Avg EPS beat(8)2.63%
EPS beat(12)6
Avg EPS beat(12)-21.09%
EPS beat(16)9
Avg EPS beat(16)89.52%
Revenue beat(2)0
Avg Revenue beat(2)-1.28%
Min Revenue beat(2)-1.75%
Max Revenue beat(2)-0.81%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-1.75%
Max Revenue beat(4)0.06%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)3
Avg Revenue beat(12)-1.05%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)0%
PT rev (3m)3.66%
EPS NQ rev (1m)5.78%
EPS NQ rev (3m)-7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.02%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)2.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.31 | ||
| Fwd PE | 16.47 | ||
| P/S | 1.04 | ||
| P/FCF | 11.15 | ||
| P/OCF | 8.24 | ||
| P/B | 0.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.49 |
EPS(TTM)0.39
EY4.48%
EPS(NY)0.53
Fwd EY6.07%
FCF(TTM)0.78
FCFY8.97%
OCF(TTM)1.06
OCFY12.14%
SpS8.36
BVpS9.34
TBVpS-4.39
PEG (NY)0.87
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.7% | ||
| ROE | -3.27% | ||
| ROCE | 1.67% | ||
| ROIC | 1.2% | ||
| ROICexc | 1.22% | ||
| ROICexgc | 6.93% | ||
| OM | 3.38% | ||
| PM (TTM) | N/A | ||
| GM | 49.51% | ||
| FCFM | 9.34% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
ROICexc(3y)0.6%
ROICexc(5y)N/A
ROICexgc(3y)3.44%
ROICexgc(5y)N/A
ROCE(3y)0.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y24.24%
ROICexc growth 3YN/A
ROICexc growth 5Y27.79%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.35 | ||
| Debt/EBITDA | 5.23 | ||
| Cap/Depr | 25.41% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 0.6 | ||
| Cash Conversion | 77.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 0.82 |
F-Score6
WACC6.99%
ROIC/WACC0.17
Cap/Depr(3y)18.24%
Cap/Depr(5y)15.74%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y25.49%
EPS Next 2Y13.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.88%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%9.94%
Revenue Next Year10.6%
Revenue Next 2Y10.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y131.6%
EBIT growth 3YN/A
EBIT growth 5Y36.31%
EBIT Next Year85.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.01%
FCF growth 3Y58.7%
FCF growth 5Y157.47%
OCF growth 1Y41.8%
OCF growth 3Y52.18%
OCF growth 5Y50.41%